You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Journal of the Renin-Angiotensin-Aldosterone System

Impact Factor: 4.1 / 5-Year Impact Factor: 2.5

Journal Homepage Submission guidelines

Restricted access

Other

First published online 2007-06

A brief response to Sealey and Laragh

Volume 8, Issue 2

https://doi.org/10.3317/jraas.2007.020

Abstract

Keywords

aliskiren angiotensin-converting enzyme inhibitors reninihibition

Get full access to this article

View all access options for this article.

References

1.

Sealey JE , Laragh JH Aliskiren, the first renin inhibitor for treating hypertension: reactive renin secretion may limit its effectiveness. AJH 2007;20:587-97.

Browse journal

All articles Browse by year

Similar articles

Retricted access

Grossly elevated serum angiotensin-converting enzyme activities are still suppressible with ACE inhibitor therapy

Retricted access

Discordant responses to two classes of drugs acting on the renin-angiotensin system

Retricted access

The role of angiotensin receptor blockers in reducing the risk of cardiovascular disease

Retricted access

Review: Prospects for ARB in the next five years